Report Says 'Pervasive Abuse' Of Patents Boosts Drug Prices
A nonprofit group whose criticism of drug patents has been both embraced and condemned by members of Congress has issued a new report arguing that "pervasive abuse of the U.S. drug...To view the full article, register now.
Already a subscriber? Click here to view full article